Addex Therapeutics (ADXN) vs NuCana (NCNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($5.6 million vs $4.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADXN | NCNA |
|---|---|---|
| Share price | $3.18 | $1.11 |
| Market cap | $5.57M | $4.62M |
| 1-day change | 0.00% | -1.33% |
| EPS (TTM) | $-7.56 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $6.17 |
| 52-week low | $2.56 | $0.948 |
| Distance from 52-week high | -73.43% | -82.01% |
| Average volume | 138.20K | 121.25K |
| Shares outstanding | 1.75M | 4.16M |
| Employees | 3 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About NuCana
NCNA stock →NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
ADXN vs NCNA FAQ
Which is bigger, Addex Therapeutics or NuCana?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $5.57M compared with $4.62M for NuCana (NCNA).
Are Addex Therapeutics and NuCana in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.